AxoGen, Inc. (OTCBB: AXGN) a leader in the science and commercialization of surgical solutions for peripheral nerve repair, today announced that it will be presenting at Noble Financial Capital Markets' Ninth Annual Equity Conference to be held at the Hard Rock Hotel in Hollywood, Florida. Greg Freitag, AxoGen’s Chief Financial Officer, will give a Company presentation on Tuesday, January 22, 2013, at 1:30 PM Eastern Time.
The Company also announced that a live audio broadcast of its conference presentation will be available. To access the broadcast, listeners should go to the Company's website, http://www.axogeninc.com/investors.html. A replay of the conference presentation will also be available through the Company's website following the live audio broadcast
About AxoGen, Inc.
AxoGen (OTCBB: AXGN) is a leading regenerative medicine company dedicated to advancing the science and commercialization of peripheral nerve repair solutions. AxoGen’s products offer a full suite of surgical nerve reconstruction solutions including Avance® Nerve Graft, the only commercially available processed nerve allograft for bridging severed nerves, AxoGuard® Nerve Connector, a coaptation aid allowing for close approximation of severed nerves, and AxoGuard® Nerve Protector, a bioscaffold used to reinforce a coaptation site, wrap a partially severed nerve or isolate and protect nerve tissue. For more information, visit our website at www.axogeninc.com.